PADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/VIAL
Product details
Registration number: SIN16502P
Classification: Prescription Only
Active ingredients: Enfortumab vedotin
Strength: 20.0 mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: ASTELLAS PHARMA SINGAPORE PTE. LTD.
ATC code: L01FX13
HSA approval date: 30 May 2022
Manufacturer(s): Simtra Deutschland GmbH (DP manufacturer & Primary packager)
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for PADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16502P
Classification: Prescription Only
What active ingredients and strength are recorded for PADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Enfortumab vedotin
Strength: 20.0 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for PADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for PADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: ASTELLAS PHARMA SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for PADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Simtra Deutschland GmbH (DP manufacturer & Primary packager)
Manufacturing country/countries: GERMANY
Where can I look up PADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16502P or the exact product name PADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/VIAL. The general register link does not preselect this product.
What are the source dates for this PADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this PADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16502P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)